Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
3 Dividend Aristocrats to Own For a Lifetime Of Passive Income
01:45pm, Wednesday, 20'th May 2026
Paychecks stop. Bonuses get cut.
FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer
12:54pm, Wednesday, 20'th May 2026
Johnson & Johnson offers a superior return/risk profile versus Pfizer, driven by consistency and operational stability. PFE's far lower valuation (FWD P/E 8.55x, PEGY 0.97x) and far higher yield (6.79
How Much Do You Really Need Invested to Replace a $40,000 Salary at 62 and Bridge the Five Years Until Social Security at 67?
11:32am, Wednesday, 20'th May 2026
A $40,000 annual income is often enough for a 62-year-old retiree living modestly while bridging the five years until full Social Security benefits begin at 67. The challenge is generating that income
These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets
02:30pm, Tuesday, 19'th May 2026
ExxonMobil, Johnson and Johnson, and Coca-Cola are safe stocks to buy and forget.
Johnson & Johnson (JNJ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
02:20pm, Tuesday, 19'th May 2026
Johnson & Johnson (JNJ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth
12:21pm, Tuesday, 19'th May 2026
J&J's expanding pipeline, new drug approvals and rising sales from cancer medicines are expected to fuel growth.
3 Dividend Kings to Buy and Hold for 20 Years
11:30am, Tuesday, 19'th May 2026
When it comes to reliable dividend payouts, these three companies keep rewarding their long-term shareholders.
This Will Be Johnson and Johnson's Stock Price in 2027
10:21am, Tuesday, 19'th May 2026
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) closed the most recent session at $230.42, up 2.58% on the week as buyers rotated back into
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Tuesday, 19'th May 2026
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Portal Innovations, in partnership with the New Brunswick Development Corporation (DEVCO) and HELIX, today announced that Johnson & Johnson has secured naming rig
Meet the Dividend King With a Higher Credit Rating Than the U.S. Government
07:30am, Tuesday, 19'th May 2026
Johnson & Johnson's business can perform well under the most challenging conditions. The company's credit rating and dividend track record provide strong evidence of the business's strength.
Cancer Stocks That Are Advancing the Future of Oncology Care
01:01pm, Monday, 18'th May 2026
Oncology innovation is accelerating as AI, immunotherapy and targeted drugs drive growth for cancer-focused biotech and pharma stocks.
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
12:47pm, Monday, 18'th May 2026
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Is JNJ Overvalued? DCF Says Worth $122
07:10am, Monday, 18'th May 2026
On May 18, 2026, we delve into the DCF analysis for Johnson and Johnson (JNJ), a company that has shown a remarkable price performance over the past year with a g
3 Dividend Stocks Warren Buffett Would Buy in a Market Crash
07:30pm, Sunday, 17'th May 2026
A stock market crash doesn't appear imminent, but there's no harm in being prepared. Many investors will head for the hills in a market downturn, but Warren Buffett would capitalize on the opportunity
